| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |